Home
/
Products
/
Services
/
Resource
Citations Database Download
/
News
/
Genomeditech
About History Honor Contact Careers
/
Contact
EN
EN
CN
Lentivirus
Cell Line Development
Protein Expression
Plasmid DNA Preparation Services
Adeno-associated Virus
Cell-based Assay
Antibody Services
Reporter Gene Detection Services
Plasmid
Cell lines
Cytokines Immune checkpoints GPCR CLDN TAA Kinase TLR NK Antibody function Immunotherapy target In vivo imaging TNF LILR WNT Others Reference cells
Molecular Reference Standards
Reporter gene detection-related reagents
Lentivirus
Proteins
Cytokines TAA Immune checkpoints Immunotherapy target GPCR TNF Kinase Others
Pseudovirus control material
Reagents related to cell function detection and analysis
Adeno-Associated Virus (AAV)
Antibodies
In Vivo MAb Antibodies Anti-payload antibodies Loading Controls Antibodies & Tag Antibodies Biosimilar Antibodies
Pseudovirus
Genoagent (Brand name of reagents)
News
Insights
search
CN
Search
Home
Products
Plasmid Cell lines Molecular Reference Standards Reporter gene detection-related reagents Lentivirus Proteins Pseudovirus control material Reagents related to cell function detection and analysis Adeno-Associated Virus (AAV) Antibodies Pseudovirus Genoagent (Brand name of reagents)
Services
Lentivirus Adeno-associated Virus Cell Line Development Cell-based Assay Plasmid DNA Preparation Services Protein Expression Antibody Services Reporter Gene Detection Services
Resource
Citations Database Download
News
News
Genomeditech
About History Honor Contact Careers
News
Insights
Current position：News > News > Insights
Insights
HER2: FDA Approves Application for Phase I Clinical Trial of Paragon HER2 ADC for Solid Tumours
2024-11-08
AstraZeneca Announces Data from First-in-Human Phase 1 Study of AZD0486, a Novel CD19xCD3 T-Cell Activator, in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
2024-11-08
GLP-1R/GCGR/GIPR: Novo Nordisk Signs $285M GLP-1 Deal With Danish Neighbor Ascendis
2024-11-06
BTK：Sanofi Announces Positive Data from Phase III Study of BTK Inhibitor ITP
2024-11-06
CD19/CD20/CD3：GSK enters agreement to acquire CMG1A46 from Chimagen Bioscience
2024-11-01
PD-1/VEGF：GlycoMimetics enters into acquisition agreement with Crescent biopharma
2024-11-01
IL-17: UCB presents new 4-year data for BIMZELX[®](bimekizumab) in moderate to severe plaque psoriasis at EADV 2024
2024-09-25
CD40: UCB and Biogen Announce Positive Topline Results From Phase 3 Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus
2024-09-25
CD38: Sarclisa approved in the US as the first anti-CD38 therapy in combination with standard-of-care treatment for adult patients with newly diagnosed multiple myeloma not eligible for transplant
2024-09-23
First 1 Last
Total 1 Page
Jump
Current position：News > News > Insights
classify
Insights
HER2: FDA Approves Application for Phase I Clinical Trial of Paragon HER2 ADC for Solid Tumours
2024-11-08
AstraZeneca Announces Data from First-in-Human Phase 1 Study of AZD0486, a Novel CD19xCD3 T-Cell Activator, in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
2024-11-08
GLP-1R/GCGR/GIPR: Novo Nordisk Signs $285M GLP-1 Deal With Danish Neighbor Ascendis
2024-11-06
BTK：Sanofi Announces Positive Data from Phase III Study of BTK Inhibitor ITP
2024-11-06
CD19/CD20/CD3：GSK enters agreement to acquire CMG1A46 from Chimagen Bioscience
2024-11-01
PD-1/VEGF：GlycoMimetics enters into acquisition agreement with Crescent biopharma
2024-11-01
IL-17: UCB presents new 4-year data for BIMZELX[®](bimekizumab) in moderate to severe plaque psoriasis at EADV 2024
2024-09-25
CD40: UCB and Biogen Announce Positive Topline Results From Phase 3 Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus
2024-09-25
CD38: Sarclisa approved in the US as the first anti-CD38 therapy in combination with standard-of-care treatment for adult patients with newly diagnosed multiple myeloma not eligible for transplant
2024-09-23
MORE
News
Insights
Products
Plasmid Lentivirus Adeno-associated virus Cell lines Proteins Antibodies Molecular Reference Standards Pseudovirus control material pseudovirus Reporter gene detection-related reagents Reagents related to cell function detection and analysis Genoagent (Brand name of reagents)
Services
Lentivirus Cell line Development Protein Expression Plasmid DNA Preparation Services Adeno-associated Virus Cell-based Assay Antibody Services Reporter Gene Detection Services
Social Media
Linkedin Twitter
Follow us
Wechat public account
Resource
Citations Database Download
About Genomeditech
About History Honor Contact Careers
Toll-free hotline：400-627-9288
Email address：mkt.genomeditech@gmail.com
Company address：5th Floor, Building 1, Lane 299, Kangwei Road, Pudong New District, Shanghai
Copyright © 2023 吉满生物科技（上海）有限公司 All rights reserved.
Tel: 400-627-9288
Message consultation
reset
submit
Toll-free hotline：400-627-9288
Email address：mkt.genomeditech@gmail.com
Company address：5th Floor, Building 1, Lane 299, Kangwei Road, Pudong New District, Shanghai
Copyright © 2023 吉满生物科技（上海）有限公司 All rights reserved.
Service
WhatApp
Phone
Message
Message consultation
reset
submit